Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $3.11 Million - $4.15 Million
30,500 Added 30.5%
130,500 $16.8 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $8.78 Million - $10.5 Million
100,000 New
100,000 $10.3 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Alphadyne Asset Management LP Portfolio

Follow Alphadyne Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphadyne Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Alphadyne Asset Management LP with notifications on news.